Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
- PMID: 33462434
- PMCID: PMC7914224
- DOI: 10.1038/s41564-020-00837-0
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
Abstract
Fungi of the order Mucorales cause mucormycosis, a lethal infection with an incompletely understood pathogenesis. We demonstrate that Mucorales fungi produce a toxin, which plays a central role in virulence. Polyclonal antibodies against this toxin inhibit its ability to damage human cells in vitro and prevent hypovolemic shock, organ necrosis and death in mice with mucormycosis. Inhibition of the toxin in Rhizopus delemar through RNA interference compromises the ability of the fungus to damage host cells and attenuates virulence in mice. This 17 kDa toxin has structural and functional features of the plant toxin ricin, including the ability to inhibit protein synthesis through its N-glycosylase activity, the existence of a motif that mediates vascular leak and a lectin sequence. Antibodies against the toxin inhibit R. delemar- or toxin-mediated vascular permeability in vitro and cross react with ricin. A monoclonal anti-ricin B chain antibody binds to the toxin and also inhibits its ability to cause vascular permeability. Therefore, we propose the name 'mucoricin' for this toxin. Not only is mucoricin important in the pathogenesis of mucormycosis but our data suggest that a ricin-like toxin is produced by organisms beyond the plant and bacterial kingdoms. Importantly, mucoricin should be a promising therapeutic target.
Figures
Similar articles
-
Fungal pathogenesis: A new venom.Curr Biol. 2021 Apr 26;31(8):R391-R394. doi: 10.1016/j.cub.2021.03.015. Curr Biol. 2021. PMID: 33905698
-
Inhibition of EGFR Signaling Protects from Mucormycosis.mBio. 2018 Aug 14;9(4):e01384-18. doi: 10.1128/mBio.01384-18. mBio. 2018. PMID: 30108171 Free PMC article.
-
Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.Med Mycol. 2013 Jan;51(1):72-82. doi: 10.3109/13693786.2012.690107. Epub 2012 Jun 11. Med Mycol. 2013. PMID: 22686246
-
Update on mucormycosis pathogenesis.Curr Opin Infect Dis. 2013 Dec;26(6):508-15. doi: 10.1097/QCO.0000000000000008. Curr Opin Infect Dis. 2013. PMID: 24126718 Free PMC article. Review.
-
Pathogenesis of mucormycosis.Clin Infect Dis. 2012 Feb;54 Suppl 1(Suppl 1):S16-22. doi: 10.1093/cid/cir865. Clin Infect Dis. 2012. PMID: 22247441 Free PMC article. Review.
Cited by
-
Trans-kingdom fungal pathogens infecting both plants and humans, and the problem of azole fungicide resistance.Front Microbiol. 2024 Feb 12;15:1354757. doi: 10.3389/fmicb.2024.1354757. eCollection 2024. Front Microbiol. 2024. PMID: 38410389 Free PMC article. Review.
-
From Spores to Solutions: A Comprehensive Narrative Review on Mucormycosis.Diagnostics (Basel). 2024 Jan 31;14(3):314. doi: 10.3390/diagnostics14030314. Diagnostics (Basel). 2024. PMID: 38337830 Free PMC article. Review.
-
Experimental Models to Study the Pathogenesis and Treatment of Mucormycosis.J Fungi (Basel). 2024 Jan 22;10(1):85. doi: 10.3390/jof10010085. J Fungi (Basel). 2024. PMID: 38276032 Free PMC article. Review.
-
Fungal and mycotoxin contaminants in cannabis and hemp flowers: implications for consumer health and directions for further research.Front Microbiol. 2023 Oct 19;14:1278189. doi: 10.3389/fmicb.2023.1278189. eCollection 2023. Front Microbiol. 2023. PMID: 37928692 Free PMC article. Review.
-
Mucormycosis in 2023: an update on pathogenesis and management.Front Cell Infect Microbiol. 2023 Sep 21;13:1254919. doi: 10.3389/fcimb.2023.1254919. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37808914 Free PMC article. Review.
References
-
- Gleissner B, Schilling A, Anagnostopolous I, Siehl I & Thiel E Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 45, 1351–1360 (2004). - PubMed
-
- Kauffman CA Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 39, 588–590 (2004). - PubMed
-
- Kontoyiannis DP, Wessel VC, Bodey GP & Rolston KV Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 30, 851–856 (2000). - PubMed
-
- Marr KA, Carter RA, Crippa F, Wald A & Corey L Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34, 909–917 (2002). - PubMed
-
- Siwek GT et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 39, 584–587 (2004). - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
